Brian M Culley Lineage Cell Therapeutics, Inc. (LCTX) insider trading activity

LCTX Quotes by TradingView

Brian M Culley is President and CEO of Lineage Cell Therapeutics, Inc.. Currently has a direct ownership of 213,544 shares of LCTX, which is worth approximately $175,106. The most recent transaction as insider was on Dec 31, 2020, when has been sold 15,450 shares (Common Shares, no par value) at a price of $1.76 per share, resulting in proceeds of $27,192. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 214K
0% 3M change
37.91% 12M change
Total Value Held $175,106

Brian M Culley Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 31 2020
BUY
Exercise of conversion of derivative security
$27,192 $1.76 p/Share
15,450 Added 7.49%
190,945 Common Shares, no par ...
Sep 30 2020
SELL
Payment of exercise price or tax liability
$5,022 $0.94 p/Share
5,343 Reduced 2.95%
175,495 Common Shares, no par ...
Sep 30 2020
BUY
Exercise of conversion of derivative security
$14,523 $0.94 p/Share
15,450 Added 7.87%
180,838 Common Shares, no par ...
BMC

Brian M Culley

President and CEO
Carlsbad, CA

Track Institutional and Insider Activities on LCTX

Follow Lineage Cell Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LCTX shares.

Notify only if

Insider Trading

Get notified when an Lineage Cell Therapeutics, Inc. insider buys or sells LCTX shares.

Notify only if

News

Receive news related to Lineage Cell Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LCTX